Alps Advisors Inc. increased its stake in shares of Uranium Royalty Corp. (NASDAQ:UROY - Free Report) by 9.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,991,153 shares of the company's stock after buying an additional 269,810 shares during the quarter. Alps Advisors Inc. owned about 2.24% of Uranium Royalty worth $5,264,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Renaissance Technologies LLC purchased a new stake in shares of Uranium Royalty during the 4th quarter worth approximately $1,062,000. CenterBook Partners LP raised its holdings in Uranium Royalty by 890.9% in the 4th quarter. CenterBook Partners LP now owns 3,435,097 shares of the company's stock valued at $7,523,000 after acquiring an additional 3,088,434 shares during the last quarter. Millennium Management LLC increased its holdings in shares of Uranium Royalty by 3,613.3% during the 4th quarter. Millennium Management LLC now owns 518,784 shares of the company's stock worth $1,136,000 after buying an additional 504,813 shares during the last quarter. Accordant Advisory Group Inc increased its holdings in shares of Uranium Royalty by 718.9% during the 1st quarter. Accordant Advisory Group Inc now owns 2,334,486 shares of the company's stock worth $4,109,000 after buying an additional 2,049,409 shares during the last quarter. Finally, Squarepoint Ops LLC increased its holdings in shares of Uranium Royalty by 298.9% during the 4th quarter. Squarepoint Ops LLC now owns 43,964 shares of the company's stock worth $96,000 after buying an additional 32,943 shares during the last quarter. Hedge funds and other institutional investors own 24.19% of the company's stock.
Analyst Upgrades and Downgrades
Separately, HC Wainwright lowered their price target on Uranium Royalty from $7.70 to $4.50 and set a "buy" rating for the company in a report on Tuesday, April 22nd.
Read Our Latest Analysis on UROY
Uranium Royalty Stock Up 0.8%
Shares of Uranium Royalty stock traded up $0.02 during trading hours on Tuesday, hitting $2.47. 2,394,183 shares of the company's stock traded hands, compared to its average volume of 2,464,869. The stock has a 50 day simple moving average of $2.25 and a 200-day simple moving average of $2.11. Uranium Royalty Corp. has a twelve month low of $1.43 and a twelve month high of $3.12.
Uranium Royalty Company Profile
(
Free Report)
Uranium Royalty Corp. operates as a pure-play uranium royalty company. It acquires, accumulates, and manages a portfolio of geographically diversified uranium interests. The company has royalty interests in the McArthur River, Cigar Lake / Waterbury Lake, Roughrider, Russell Lake, Russell Lake south, and Dawn Lake projects in Saskatchewan, Canada; Anderson and San Rafael projects in Arizona; Lance and Reno Creek projects in Wyoming; Church Rock and Roca Honda projects in New Mexico; Dewey-Burdock project in South Dakota; Slick Rock project in Colorado; Langer Heinrich project in Namibia; and Michelin project in Newfoundland and Labrador, Canada; Energy Queen and Whirlwind project in Utah; and Workman Creek projects in Arizona.
Further Reading

Before you consider Uranium Royalty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Uranium Royalty wasn't on the list.
While Uranium Royalty currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.